Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Isaacs

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Clinical Therapeutics|June 15, 2019
Potential Pharmacologic Targets for the Prevention of Rheumatoid ArthritisJohn D Isaacs, Kundan Iqbal
Methods in Molecular Medicine|November 7, 2007
Differential display reverse transcription-polymerase chain reaction to identify novel biomolecules in arthritis researchManir Ali, John D Isaacs
Seminars in Arthritis and Rheumatism|October 24, 2018
Therapeutic tolerance in autoimmune diseaseFiona Rayner, John D Isaacs
Annals of the Rheumatic Diseases|November 12, 2010
The need for personalised medicine for rheumatoid arthritisJohn D Isaacs, Gianfranco Ferraccioli
Annals of the Rheumatic Diseases|August 28, 2016
Clinical trials of biosimilars should become more similarJonathan Kay, John D Isaacs
Current Pharmaceutical Design|March 12, 2015
Rheumatoid arthritis: an evolutionary force in biologicsPhilip M Brown, John D Isaacs
Current Opinion in Rheumatology|January 1, 2014
Prospects for therapeutic tolerance in humansKenneth F Baker, John D Isaacs
Annals of the Rheumatic Diseases|November 4, 2018
Tolerising cellular therapies: what is their promise for autoimmune disease?Chijioke H Mosanya, John D Isaacs
Best Practice & Research. Clinical Rheumatology|December 8, 2014
Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspectsArthur G Pratt, John D Isaacs
Clinical Medicine (London, England)|December 4, 2014
Rheumatoid arthritis: from palliation to remission in two decadesPhilip M Brown, John D Isaacs
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Clinical Therapeutics|June 15, 2019
Potential Pharmacologic Targets for the Prevention of Rheumatoid ArthritisJohn D Isaacs, Kundan Iqbal
Methods in Molecular Medicine|November 7, 2007
Differential display reverse transcription-polymerase chain reaction to identify novel biomolecules in arthritis researchManir Ali, John D Isaacs
Seminars in Arthritis and Rheumatism|October 24, 2018
Therapeutic tolerance in autoimmune diseaseFiona Rayner, John D Isaacs
Annals of the Rheumatic Diseases|November 12, 2010
The need for personalised medicine for rheumatoid arthritisJohn D Isaacs, Gianfranco Ferraccioli
Annals of the Rheumatic Diseases|August 28, 2016
Clinical trials of biosimilars should become more similarJonathan Kay, John D Isaacs
Current Pharmaceutical Design|March 12, 2015
Rheumatoid arthritis: an evolutionary force in biologicsPhilip M Brown, John D Isaacs
Current Opinion in Rheumatology|January 1, 2014
Prospects for therapeutic tolerance in humansKenneth F Baker, John D Isaacs
Annals of the Rheumatic Diseases|November 4, 2018
Tolerising cellular therapies: what is their promise for autoimmune disease?Chijioke H Mosanya, John D Isaacs
Best Practice & Research. Clinical Rheumatology|December 8, 2014
Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspectsArthur G Pratt, John D Isaacs
Clinical Medicine (London, England)|December 4, 2014
Rheumatoid arthritis: from palliation to remission in two decadesPhilip M Brown, John D Isaacs
Pageof 24